Literature DB >> 9886420

Role of the 75-kDa TNF receptor in TNF-induced activation of neutrophil respiratory burst.

P Dri1, E Haas, R Cramer, R Menegazzi, C Gasparini, R Martinelli, P Scheurich, P Patriarca.   

Abstract

The exclusive role of the 55-kDa TNF receptor (TNF-R55) as the signaling receptor in TNF-induced activation of respiratory burst by human polymorphonuclear leukocytes residing on biologic surfaces has been inferred from results obtained with receptor-specific monoclonal and polyclonal Abs. In this work, we confirm this assumption by a more direct approach, i.e., by using receptor-specific TNF mutants (p55TNF and p75TNF) and, as a novel contribution, we show that cooperation of the 75-kDa TNF receptor (TNF-R75) is required for a full blown response to the cytokine. This conclusion stems from three sets of data: 1) none of the TNF-R55-specific agonists used, i.e., mAbs or p55TNF, induced a respiratory burst comparable with that induced by TNF; 2) selective down-modulation of TNF-R75 resulted in a diminished response to TNF but not to TNF-R55-specific agonists or to the chemotactic peptide FMLP; and 3) mAbs that either block or stabilize binding of TNF to TNF-R75 inhibited the response to the cytokine, suggesting that cooperation requires not only TNF binding to the receptor but also an appropriate dissociability from it. The inhibitory effect of the Abs increased as the cytokine concentrations decreased, indicating that cooperation by TNF-R75 becomes more relevant at low TNF doses. Such a cooperation does not seem to rely on the activation of a TNF-R75-linked signaling pathway independent of TNF-R55, since the response to p55TNF and p75TNF given in combination was not higher than the response to p55TNF alone. The possible mechanisms of cooperation are discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9886420

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Characterization of TNF receptor subtype expression and signaling on pulmonary endothelial cells in mice.

Authors:  Szabolcs Bertok; Michael R Wilson; Anthony D Dorr; Justina O Dokpesi; Kieran P O'Dea; Nandor Marczin; Masao Takata
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-03-04       Impact factor: 5.464

2.  Tumor necrosis factor alpha is a proximal mediator of synergistic hepatotoxicity from trovafloxacin/lipopolysaccharide coexposure.

Authors:  Patrick J Shaw; Patricia E Ganey; Robert A Roth
Journal:  J Pharmacol Exp Ther       Date:  2008-09-26       Impact factor: 4.030

3.  Tumour necrosis factor receptors and apoptosis of alveolar macrophages during early infection with attenuated and virulent Mycobacterium bovis.

Authors:  Michele F Rodrigues; Caio C S Alves; Bárbara B M Figueiredo; Alice B Rezende; Sabine Wohlres-Viana; Vânia Lúcia da Silva; Marco Antônio Machado; Henrique C Teixeira
Journal:  Immunology       Date:  2013-08       Impact factor: 7.397

4.  Coexposure of mice to trovafloxacin and lipopolysaccharide, a model of idiosyncratic hepatotoxicity, results in a unique gene expression profile and interferon gamma-dependent liver injury.

Authors:  Patrick J Shaw; Amy C Ditewig; Jeffrey F Waring; Michael J Liguori; Eric A Blomme; Patricia E Ganey; Robert A Roth
Journal:  Toxicol Sci       Date:  2008-10-16       Impact factor: 4.849

Review 5.  Neutrophil cell surface receptors and their intracellular signal transduction pathways.

Authors:  Krisztina Futosi; Szabina Fodor; Attila Mócsai
Journal:  Int Immunopharmacol       Date:  2013-08-30       Impact factor: 4.932

6.  Co-expression of TNF receptors 1 and 2 on melanomas facilitates soluble TNF-induced resistance to MAPK pathway inhibitors.

Authors:  Cindy A Sander; Elizabeth A Rush; Jian Shi; Lidia M R B Arantes; Raymond J Tesi; Mark A Ross; Michael J Calderon; Simon C Watkins; John M Kirkwood; Robert L Ferris; Lisa H Butterfield; Lazar Vujanovic
Journal:  J Transl Med       Date:  2022-07-25       Impact factor: 8.440

7.  Small tumor necrosis factor receptor biologics inhibit the tumor necrosis factor-p38 signalling axis and inflammation.

Authors:  Violet R Mukaro; Alex Quach; Michelle E Gahan; Bernadette Boog; Zhi H Huang; Xiuhui Gao; Carol Haddad; Suresh Mahalingam; Charles S Hii; Antonio Ferrante
Journal:  Nat Commun       Date:  2018-04-10       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.